Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801762 · ClinicalTrials.gov registry record
Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology
A clinical trial of Bladder Cancer, sponsored by Stanford University.
- Completed
- Registry status
- 195
- Enrollment target
- 1
- Study location
NCT00801762: Completed study of Bladder Cancer, sponsored by Stanford University.
NCT00801762 is a study of Bladder Cancer that has completed, run by Stanford University. The registered enrollment target is 195 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00801762, a study of Bladder Cancer, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.
Conditions Studied
Interventions
- DEVICE Fibered confocal microscope
Study Locations (1)
California
- VA Palo Alto Health Care System - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-02 |
What the finished NCT00801762 record still lists
NCT00801762 is an observational study that tracks outcomes without assigning an intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 1 intervention - of which Fibered confocal microscope is the first listed.
NCT00801762 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00801762 about?
NCT00801762 is a clinical study titled "Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology". The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.
What is the current status of trial NCT00801762?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2008-09. Estimated completion is 2015-02.
What conditions does trial NCT00801762 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT00801762?
The interventions under investigation include: Fibered confocal microscope (DEVICE).
Who is sponsoring clinical trial NCT00801762?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801762 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00801762's enrollment target sits among peer trials
195 58th of 175 higher than 118 of 175 other Bladder Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bladder Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia